Holen Sie sich die Stockscreener-App
1.05
12.90%
0.12
Handel nachbörslich:
1.05
Tivic Health Systems Inc Aktie (TIVC) Neueste Nachrichten
Tivic Health Selected to Present Entolimod™ as a Radiation Countermeasure and its Plans for an Oral Transmucosal Program to the Department of War Tech Watch Program on May 7th - Star Local Media
Tivic Health outlines $20B oncology market opportunity following strategic transformation - MSN
Tivic Health (NASDAQ: TIVC) sets $50M Tumim equity line and registers shares - Stock Titan
Options Flow: What are Tivic Health Systems Incs earnings expectations2026 Dividend Review & Weekly Setup with High ROI Potential - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
TIVC Stock Price, Quote & Chart | TIVIC HEALTH SYSTEMS INC (NASDAQ:TIVC) - ChartMill
Short Covering: What is Tivic Health Systems Incs market position2026 Volume & Capital Protection Trade Alerts - baoquankhu1.vn
Reviewing Omnicell (NASDAQ:OMCL) & Tivic Health Systems (NASDAQ:TIVC) - Defense World
Valuation Update: How sensitive is Tivic Health Systems Inc to inflationRecession Risk & Real-Time Volume Triggers - baoquankhu1.vn
The Ministry of Health is interested in a new, still poorly researched drug against radiation damage. The agency sent a request to the developerthe American biotech company Tivic Health Systems. Here's what we learned - dev.ua
Tivic Health Systems Touts Entolimod Phase 3 ARS Path, Eyes BLA in 2027-2028 at Conference - Defense World
Tivic Health Systems Stock (TIVC) Opinions on Emerging Growth Conference Presentation - Moomoo
12 Health Care Stocks Moving In Thursday's After-Market SessionBullfrog AI Hldgs (NASDAQ:BFRG), CDT Eq - Benzinga
TIVC | Tivic Health Systems, Inc. FinancialsIncome Statement - Quiver Quantitative
Valauri buys Tivic Health (TIVC) shares worth $18,008 By Investing.com - Investing.com South Africa
TIVC | Tivic Health Systems, Inc. Insider Trading - Quiver Quantitative
Valauri buys Tivic Health (TIVC) shares worth $18,008 - Investing.com
Tivic Health (TIVC) director adds 19,000 shares in open-market buy - Stock Titan
TIVC: Entolimod advances toward BLA submission for ARS, with strong clinical and government interest - TradingView — Track All Markets
TIVC: Entolimod nears BLA submission for ARS, targeting major oncology and radiation markets - TradingView
Tivic CEO To Present at the Upcoming Emerging Growth's April 2026 Virtual Conference - ACCESS Newswire
Tivic Health receives Ukraine request for radiation treatment By Investing.com - za.investing.com
Tivic Receives Formal Request for Information from Ukrainian Ministry of Health Regarding Strategic Stockpiling of Entolimod - ACCESS Newswire
Tivic Health receives Ukraine request for radiation treatment - Investing.com
Ukraine weighs Tivic radiation drug for emergency reserves - Stock Titan
Tivic Health Systems Q4 2025 Earnings Call Transcript - MarketBeat
Tivic Health Systems, Inc. (NASDAQ:TIVC) Q1 2025 Earnings Call Transcript - MSN
Tivic Health Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Tivic Health (NASDAQ: TIVC) bets on Entolimod and CDMO build-out despite losses - Stock Titan
Tivic CEO to present at the Upcoming Emerging Growth's April 2026 Virtual Conference - marketscreener.com
Tivic CEO To Present at Emerging Growth Virtual Conference - National Today
Tivic Health Systems, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
New Tivic CEO to spotlight NIAID radiation study deal online - stocktitan.net
Tivic Health secures NIH funding for radiation syndrome study By Investing.com - Investing.com South Africa
Tivic Secures NIAID Non-Clinical Evaluation Agreement for Entolimod, Targeting Gastrointestinal Acute Radiation Syndrome - National Today
Tivic Health secures NIH funding for radiation syndrome study - Investing.com
U.S.-funded Tivic study targets deadly gut damage after radiation - Stock Titan
Tivic Health Systems, Inc. Relocates Headquarters to San Antonio, Texas and Discontinues ClearUP Operations - Minichart
Earnings call transcript: Tivic Health pivots to biopharma focus in Q4 2025 By Investing.com - Investing.com South Africa
Earnings call transcript: Tivic Health pivots to biopharma focus in Q4 2025 - Investing.com India
TIVC: Transformed into an immunotherapy-focused company with expanded manufacturing and strong cash reserves - TradingView
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Transcript : Tivic Health Systems, Inc., 2025 Pre Recorded Earnings Call, Mar 25, 2026 - marketscreener.com
2.40%
0.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):